ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focuson advanced or metastatic ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

A new study from the Institute of Environmental Medicine at Karolinska Institutet presents a promising method for identifying ...

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

A mass spec-based method for analyzing the structure of lipid nanoparticles could yield new insights that improve vaccine and ...

Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine ...

Currently, the researchers are using CRISPR-TO to move endogenous RNAs – RNA molecules that are naturally produced within the ...

Somatic hypermutation (SHM) of immunoglobulin variable (V) regions modulates antibody-antigen affinity is initiated by activation-induced cytidine deaminase (AID) on single-stranded DNA (ssDNA).